The XOMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XOMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The XOMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View XOMA Detailed Price Forecast - CNN Money | View XOMA Detailed Summary - Google Finance | ||
View XOMA Detailed Summary - Yahoo! Finance | View XOMA Stock Research & Analysis - Zacks.com |
View XOMA Trends & Analysis - Trade-Ideas | View XOMA Major Holders - Barrons | ||
View XOMA Call Transcripts - NASDAQ | View XOMA Breaking News & Analysis - Seeking Alpha | ||
View XOMA Annual Report - CompanySpotlight.com | View XOMA OTC Short Report - OTCShortReport.com | ||
View XOMA Fundamentals - TradeKing | View XOMA SEC Filings - Bar Chart | ||
View Historical Prices for XOMA - The WSJ | View Performance/Total Return for XOMA - Morningstar | ||
View the Analyst Estimates for XOMA - MarketWatch | View the Earnings History for XOMA - CNBC | ||
View the XOMA Earnings - StockMarketWatch | View XOMA Buy or Sell Recommendations - MacroAxis | ||
View the XOMA Bullish Patterns - American Bulls | View XOMA Short Pain Metrics - ShortPainBot.com |
View XOMA Stock Mentions - StockTwits | View XOMA Stock Mentions - PennyStockTweets | ||
View XOMA Stock Mentions - Twitter | View XOMA Investment Forum News - Investor Hub | ||
View XOMA Stock Mentions - Yahoo! Message Board | View XOMA Stock Mentions - Seeking Alpha |
View Insider Transactions for XOMA - SECform4.com | View Insider Transactions for XOMA - Insider Cow | ||
View XOMA Major Holdings Summary - CNBC | View Insider Disclosure for XOMA - OTC Markets | ||
View Insider Transactions for XOMA - Yahoo! Finance | View Institutional Holdings for XOMA - NASDAQ |
View XOMA Stock Insight & Charts - FinViz.com | View XOMA Investment Charts - StockCharts.com | ||
View XOMA Stock Overview & Charts - BarChart | View XOMA User Generated Charts - Trading View |
XOMA Corporation Announces Closing of Tender Offer
Posted on Wednesday April 03, 2024
Kinnate Stockholders to Receive $2.5879 Per Share in Cash Plus Contingent Value RightEMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Kinnate Biopharma Inc. (NASDAQ: KN
XOMA Declares Quarterly Preferred Stock Dividends
Posted on Thursday March 21, 2024
EMERYVILLE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share. Holders of depositary shares, each representing 1/1000 of a share of XOMA’s 8.375% Series
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
Posted on Tuesday March 19, 2024
Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolioEMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the “Company”; Nasdaq: XOMA) entered into a merger agreement to acquire Kinnate Biopharma Inc. (“Kinnate”; Nasdaq: KNTE) for (i) a base cash price per share of Kinnate common stock of $2.3352 per share
XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
Posted on Friday March 08, 2024
Key Financial Highlights and Upcoming Events Set to Influence Future Growth